Bevacizumab for retinopathy of prematurity.

Clare E Gilbert ORCID logo; Andrea Zin; Brian Darlow; (2011) Bevacizumab for retinopathy of prematurity. The New England journal of medicine, 364 (24). pp. 2359-2360. ISSN 0028-4793 DOI: 10.1056/NEJMc1103460
Copy
Item Type Article
Keywords Angiogenesis Inhibitors, therapeutic use, Antibodies, Monoclonal, therapeutic use, Developing Countries, Humans, Infant, Newborn, Infant, Premature, Intravitreal Injections, Laser Therapy, Retinopathy of Prematurity, drug therapy, therapy, Vascular Endothelial Growth Factor A, antagonists & inhibitors
ISI 291643800018

Explore Further

picture_as_pdf
nejmc1103460.pdf
subject
Published Version
copyright
Available under Copyright the publishers
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads